Riskpilot← Back to searchSign inGet full accessDuMed Sverige AB
ABActiveOrg 5591864003Sjöflygvägen 35 EWholesale of pharmaceutical and medical goods · NACE 4646Est. 20181 employees
Revenue 2025
SEK 17,4M
+53% vs 2024
EBITDA margin
4.0%
+1344% vs 2024
Equity ratio
7.2%
Financial strength
Net profit 2025
SEK 458K
+1288% vs 2024
| Revenue | SEK 17,4M | +53% |
| EBITDA | SEK 693K | +1344% |
| Net profit | SEK 458K | +1288% |
| Total assets | SEK 11,3M | +137% |
| Equity | SEK 813K | +129% |
| Employees | 1 | — |
Legal name
DuMed Sverige AB
Org number
5591864003
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 december 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva marknadsföring och försäljning av produkter inom området för medicinsk verksamhet, inklusive röntgen, samt därmed förenlig verksamhet.
Address
Sjöflygvägen 35 E
Email
info@dumedgroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 879 | 15 958 | 16 824 | 11 313 | 17 355 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 35 | 24 | 100 | 48 | 693 |
| Depreciation & amort. | −17 | −21 | −22 | −5 | −118 |
| EBIT | 18 | 3 | 78 | 43 | 575 |
| Net financials | −6 | −1 | — | — | 3 |
| Profit before tax | 13 | 2 | 78 | 42 | 577 |
| Tax | −5 | −1 | −16 | −9 | −119 |
| Net profit | 8 | 1 | 62 | 33 | 458 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 674 | 11 417 | 4 477 | 4 765 | 11 301 |
| Equity | 259 | 260 | 322 | 355 | 813 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 415 | 11 157 | 4 156 | 4 410 | 10 487 |
| Total debt | 1 415 | 11 157 | 4 156 | 4 410 | 10 487 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20212025
Equity ratio
7.2%
This company
38.2%
Market median
-81% vs market
20212025
Return on equity
56.3%
This company
18.4%
Market median
+206% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
1.54×
This company
1.12×
Market median
+37% vs market
20212025
Debt / equity
12.90×
This company
0.62×
Market median
-1981% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SA Chief Auditor | Chief Auditor | 2022 |
TP Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
| Former (1) | ||
SS Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DuMed Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Samuelsson | Authorized Recipient of Service | 0 companies |
| Sven Arne Richard Lindberg | Chief Auditor | 0 companies |
| Thomas Peter Blomqvist | Authorized Recipient of Service | 0 companies |
| Janny Elmholdt | Board of Directors | 0 companies |
| Niklas Ralph Göran Jeppsson | Deputy Board Member | 0 companies |
| Thomas Kreutzfeldt | Deputy Board Member | 0 companies |
| Mads Zeidler | Chairman | 0 companies |